Executing on 2027 strategic roadmap
31/10/25 -"We upgraded our target price for Leonteq, accounting for better prospects across 2025-2027, mostly helped by stronger cost-efficiency and a more supportive trading backdrop. We foresee more fee ..."
Pages
63
Language
English
Published on
31/10/25
You may also be interested by these reports :
31/10/25
Q3 revenues came in better than expected, but the company guided for a reduced range of growth for 2026. Yet several items underscore the ...
31/10/25
We upgraded our target price for Leonteq, accounting for better prospects across 2025-2027, mostly helped by stronger cost-efficiency and a more ...
30/10/25
The FY25 results slightly exceeded consensus but fell short of our projections, with a better-than-expected recurring EBITDA margin and cash ...
29/10/25
DWS delivered strong Q3-25 results, beating consensus on higher AuM and inflows driving management fees and strong operating leverage (C/I 57%). ...